Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-08-26 00:00:00 ET · period of report 2021-08-25 · accession 0001517026-21-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-26 | 2021-08-25 | MYGN | Verratti Mark | Pres, Myriad Neuroscience | F - Tax | $34.81 | -1,082 | 156.0K | -0.7% | -$37.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-25 | F | D | 1,082 | $34.81 | 156,048 | D | — | — |